NO20055352L - Nasal administrering av LH-RH analog leuprolid - Google Patents

Nasal administrering av LH-RH analog leuprolid

Info

Publication number: NO20055352L
Authority: NO; Norway
Prior art keywords: leuprolide; nasal administration; analog; analog leuprolide; hypogonadism
Prior art date: 2003-05-01

Application number

NO20055352A

Other languages

English (en)

Norwegian (no)

Inventor

Khurshid Iqbal

Anthony Fisher

Peter Watts

Original Assignee

West Pharmaceutical Service Dr

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-01

Filing date

2005-11-11

Publication date

2005-12-01

2005-11-11 Application filed by West Pharmaceutical Service Dr filed Critical West Pharmaceutical Service Dr

2005-12-01 Publication of NO20055352L publication Critical patent/NO20055352L/no

Links

108010000817 Leuprolide Proteins 0.000 title abstract 4
GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 title abstract 4
229960004338 leuprorelin Drugs 0.000 title abstract 4
XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical class C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 title 1
229920001661 Chitosan Polymers 0.000 abstract 1
201000009273 Endometriosis Diseases 0.000 abstract 1
206010058359 Hypogonadism Diseases 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
206010036618 Premenstrual syndrome Diseases 0.000 abstract 1
206010060862 Prostate cancer Diseases 0.000 abstract 1
208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
206010046798 Uterine leiomyoma Diseases 0.000 abstract 1
239000000227 bioadhesive Substances 0.000 abstract 1
201000010260 leiomyoma Diseases 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
201000007954 uterine fibroid Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Otolaryngology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pregnancy & Childbirth (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Gynecology & Obstetrics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

NO20055352A 2003-05-01 2005-11-11 Nasal administrering av LH-RH analog leuprolid NO20055352L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US46709503P	2003-05-01	2003-05-01
PCT/US2004/013498 WO2004098513A2 (fr)	2003-05-01	2004-05-03	Administration nasale de leuprolide analogue lh-rh

Publications (1)

Publication Number	Publication Date
NO20055352L true NO20055352L (no)	2005-12-01

Family

ID=33435022

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055352A NO20055352L (no)	2003-05-01	2005-11-11	Nasal administrering av LH-RH analog leuprolid

Country Status (9)

Country	Link
US (1)	US20040248804A1 (fr)
EP (1)	EP1622448A2 (fr)
JP (1)	JP2006525354A (fr)
CN (1)	CN1780555A (fr)
AU (1)	AU2004235744A1 (fr)
CA (1)	CA2524286A1 (fr)
NO (1)	NO20055352L (fr)
WO (1)	WO2004098513A2 (fr)
ZA (1)	ZA200508480B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101686986B1 (ko) *	2014-07-28	2016-12-16	에스케이케미칼주식회사	류프로라이드를 포함하는 속효성과 지속성을 동시에 갖는 약제학적 조성물

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4234571A (en) *	1979-06-11	1980-11-18	Syntex (U.S.A.) Inc.	Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
US5690954A (en) *	1987-05-22	1997-11-25	Danbiosyst Uk Limited	Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
US5059587A (en) *	1987-08-03	1991-10-22	Toyo Jozo Company, Ltd.	Physiologically active peptide composition for nasal administration
US5554388A (en) *	1989-02-25	1996-09-10	Danbiosyst Uk Limited	Systemic drug delivery compositions comprising a polycationi substance
US5744166A (en) *	1989-02-25	1998-04-28	Danbiosyst Uk Limited	Drug delivery compositions
GB9202464D0 (en) *	1992-02-05	1992-03-18	Danbiosyst Uk	Composition for nasal administration
US5446025A (en) *	1992-06-12	1995-08-29	Abbott Laboratories	Formulations and method of the percutaneous administration of leuprolide
GB9416884D0 (en) *	1994-08-20	1994-10-12	Danbiosyst Uk	Drug delivery compositions
GB9514285D0 (en) *	1995-07-13	1995-09-13	Univ Nottingham	Polymeric lamellar substrate particles for drug delivery
GB9525083D0 (en) *	1995-12-07	1996-02-07	Danbiosyst Uk	Vaccine compositions
NZ331186A (en) *	1996-02-02	2000-04-28	Alza Corp	Osmotically driven sustained delivery drug delivery capsule
GB9700624D0 (en) *	1997-01-14	1997-03-05	Danbiosyst Uk	Drug delivery composition
GB9707934D0 (en) *	1997-04-18	1997-06-04	Danbiosyst Uk	Improved delivery of drugs to mucosal surfaces
US6001396A (en) *	1997-07-08	1999-12-14	University Of Maine	Method and solution for improving frozen seafood quality
GB9725084D0 (en) *	1997-11-28	1998-01-28	Medeva Europ Ltd	Vaccine compositions
GB9726916D0 (en) *	1997-12-19	1998-02-18	Danbiosyst Uk	Nasal formulation
US6099851A (en) *	1998-06-02	2000-08-08	Weisman; Kenneth M.	Therapeutic uses of leuprolide acetate
US6565874B1 (en) *	1998-10-28	2003-05-20	Atrix Laboratories	Polymeric delivery formulations of leuprolide with improved efficacy
GB9905136D0 (en) *	1999-03-06	1999-04-28	Danbiosyst Uk	Surface modification of lamellar particles
GB9924797D0 (en) *	1999-10-20	1999-12-22	West Pharm Serv Drug Res Ltd	Compound

2004
- 2004-05-03 EP EP04760667A patent/EP1622448A2/fr not_active Withdrawn
- 2004-05-03 US US10/838,077 patent/US20040248804A1/en not_active Abandoned
- 2004-05-03 JP JP2006514192A patent/JP2006525354A/ja active Pending
- 2004-05-03 CA CA002524286A patent/CA2524286A1/fr not_active Abandoned
- 2004-05-03 CN CNA2004800117861A patent/CN1780555A/zh active Pending
- 2004-05-03 ZA ZA200508480A patent/ZA200508480B/en unknown
- 2004-05-03 AU AU2004235744A patent/AU2004235744A1/en not_active Abandoned
- 2004-05-03 WO PCT/US2004/013498 patent/WO2004098513A2/fr not_active Ceased
2005
- 2005-11-11 NO NO20055352A patent/NO20055352L/no unknown

Also Published As

Publication number	Publication date
US20040248804A1 (en)	2004-12-09
AU2004235744A1 (en)	2004-11-18
CN1780555A (zh)	2006-05-31
WO2004098513A2 (fr)	2004-11-18
ZA200508480B (en)	2007-05-30
CA2524286A1 (fr)	2004-11-18
EP1622448A2 (fr)	2006-02-08
JP2006525354A (ja)	2006-11-09
WO2004098513A3 (fr)	2005-08-25

Similar Documents

Publication	Publication Date	Title
NO20072739L (no)	2007-07-24	Stabiliserte ramiprilsammensetninger og fremgangsmater for fremstilling
NO20040917L (no)	2004-03-02	Oftamologiske depotpreparater for periokular eller subkonjunktival administrering.
NO20002605D0 (no)	2000-05-19	Speroider, fremstillingsmetode og farmasøytiske sammensetninger
SG148997A1 (en)	2009-01-29	Powders comprising low molecular dextran and methods of producing those powders
DK0801649T3 (da)	2002-12-02	Hydroxylaminderivater, der er nyttige til forøgelse af molekylærchaperonproduktion, og fremstilling deraf
DE60128251D1 (de)	2007-06-14	Östronderivate mit zellschützender wirkung
EA200300937A1 (ru)	2004-04-29	Оральная фармацевтическая композиция цефподоксима проксетила
NO20054776L (no)	2005-10-17	Kontrollert frigivelsessystem som inneholder sakkaroseacctatisobutyrat
DK1226148T3 (da)	2012-03-19	Hidtil ukendte oligosaccharider, fremstilling heraf og farmaceutiske præparater, der indeholder dem
WO2004093800A3 (fr)	2005-01-06	Derives de thyronamine et analogues et des methodes d'utilisation de ces composes
DE60307268D1 (de)	2006-09-14	Pestizide pyridincarbonsäureamidderivate
WO2004047771A3 (fr)	2005-09-15	Peptides inhibant l'angiogenese, et la migration, l'invasion et la proliferation cellulaires, compositions et leurs utilisations
AU2003903124A0 (en)	2003-07-10	Analogues of heteromeric proteins
IS5143A (is)	1999-07-30	Nímesúlíð gelkerfi til staðbundinnar notkunar
GB0216002D0 (en)	2002-08-21	Process and composition
NO20055352L (no)	2005-12-01	Nasal administrering av LH-RH analog leuprolid
NO331082B1 (no)	2011-10-03	Formulering av kahalalid F, sett omfattende en slik formulering, samt rekonstituert losning derav og anvendelse av en fortynnet rekonstituert losning til fremstilling av et medikament for behandling av kreft
WO2002030941A3 (fr)	2002-10-03	Inhibiteurs des topo-isomerases
MXPA04003526A (es)	2004-07-22	Composicion y metodo para el tratamiento de la diabetes.
WO2024137700A3 (fr)	2024-08-02	Molécules d'acide polynucléique ciblant l'agt et leurs utilisations
WO2023194699A3 (fr)	2023-11-16	Composition de vaccin
DE69920259D1 (de)	2004-10-21	Ionenkanal modulatoren
AU7525398A (en)	1998-11-11	Inhibitors for urokinase receptor
WO2020190900A8 (fr)	2021-10-14	Formulations pharmaceutiques à base d'abiratérone et d'oligomère cyclique et procédés de formation et d'administration de celles-ci
NO20054346L (no)	2005-11-04	Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander